BlueRock Therapeutics:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:BlueRock Therapeutics - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11117
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BlueRock Therapeutics is a biotechnology company that develops novel stem cell therapies to treat cardiovascular and neurodegenerative diseases. The company’s therapeutic candidate is used to treat Parkinson’s disease that restores dopamine production in the midbrain by retaining dopamine-secreting cells which are affected due to degenerative disease conditions. It also develops cardiomyocytes which are lost during the heart attack in an infarcted heart to remuscularize the heart. BlueRock Therapeutics’ therapeutic platform is based on induced pluripotent stem cells which can be generated from cells in a normal blood draw from a consenting adult and produced using cell manufacturing technologies. The company has operations in Canada and the US. BlueRock Therapeutics is headquartered in Toronto, Ontario, Canada.

BlueRock Therapeutics – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BlueRock Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
BlueRock Therapeutics Raises USD225 Million in Series A Financing 10
Partnerships 11
BlueRock Therapeutics Enters into Research Partnership with Memorial Sloan Kettering Cancer Center 11
Licensing Agreements 12
BlueRock Therapeutics Enters into Licensing Agreement with Universal Cells 12
BlueRock Therapeutics Enters into Licensing Agreement with VistaGen Therapeutics 13
Equity Offering 14
BlueRock Therapeutics Spins Out from Kyoto University 14
BlueRock Therapeutics – Key Competitors 15
BlueRock Therapeutics – Key Employees 16
BlueRock Therapeutics – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Oct 26, 2017: BlueRock Therapeutics Establishes Corporate Headquarters in Cambridge, Massachusetts and Bolsters Team to Support Rapid Growth and Development 18
Aug 17, 2017: BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub, Appoints Key R&D Leadership 19
Corporate Communications 20
Sep 20, 2018: BlueRock Therapeutics names Shane Kovacs as chief business and financial officer 20
Dec 01, 2017: BlueRock Therapeutics Announces Appointment of Derek Hei, Ph.D. as Senior VP, Manufacturing, Quality and Regulatory 21
Jun 27, 2017: BlueRock Therapeutics Announces Key Members of Executive Team 22
Government and Public Interest 23
Jan 05, 2018: Get to Know the Revolutionary Medical Innovations Being Unleashed in Canada 23
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Key Facts 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BlueRock Therapeutics, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BlueRock Therapeutics, Deals By Therapy Area, 2012 to YTD 2018 8
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
BlueRock Therapeutics Raises USD225 Million in Series A Financing 10
BlueRock Therapeutics Enters into Research Partnership with Memorial Sloan Kettering Cancer Center 11
BlueRock Therapeutics Enters into Licensing Agreement with Universal Cells 12
BlueRock Therapeutics Enters into Licensing Agreement with VistaGen Therapeutics 13
BlueRock Therapeutics Spins Out from Kyoto University 14
BlueRock Therapeutics, Key Competitors 15
BlueRock Therapeutics, Key Employees 16
BlueRock Therapeutics, Other Locations 17

List of Figures
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
BlueRock Therapeutics, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[BlueRock Therapeutics:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abbott Laboratories:企業の戦略・SWOT・財務情報
    Abbott Laboratories - Strategy, SWOT and Corporate Finance Report Summary Abbott Laboratories - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ZoomMed Inc (ZMD)-医療機器分野:企業M&A・提携分析
    Summary ZoomMed Inc (ZoomMed) is a technical service provider that offers web solutions for medical sectors. The company’s product includes ZoomMed Network, ZRx Prescriber, PraxisLab, and EvPsych. It builds and operates a clinical information exchange platform between physicians and specialists, pat …
  • The Interpublic Group of Companies, Inc.:戦略・SWOT・企業財務分析
    The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Interpublic Group of Companies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Changmao Biochemical Engineering Co., Ltd:企業の戦略・SWOT・財務分析
    Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Changmao Biochemical Engineering Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Pennon Group Plc (PNN):企業の財務・戦略的SWOT分析
    Pennon Group Plc (PNN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Cancer Research Technology Ltd-医療機器分野:企業M&A・提携分析
    Summary Cancer Research Technology Ltd (CRT), formerly Cancer Research Campaign Technology Ltd, a subsidiary of Cancer Research UK, is a research organization that develops and commercializes discoveries for treatment in the areas of cancer. The organization offers services such as project developme …
  • TenneT Holding BV:電力:M&Aディール及び事業提携情報
    Summary TenneT Holding BV (TenneT), owned by the Ministry of Finance of The State of the Netherlands, is an electricity transmission system operator. The company offers electricity transmission and system services. It constructs and maintains high voltage grid to transmit electricity from the produc …
  • Kuwait Projects Company Holding KSC (KPROJ):企業の財務・戦略的SWOT分析
    Kuwait Projects Company Holding KSC (KPROJ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Borealis AG:企業の戦略的SWOT分析
    Borealis AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Neuca SA (NEU):企業の財務・戦略的SWOT分析
    Neuca SA (NEU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Concardis Gmbh
    Concardis Gmbh - Strategy, SWOT and Corporate Finance Report Summary Concardis Gmbh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Inchcape plc:企業の戦略・SWOT・財務分析
    Inchcape plc - Strategy, SWOT and Corporate Finance Report Summary Inchcape plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • TVA Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary TVA Medical Inc (TVA Medical) is a medical device company that designs and manufactures catheter-based systems. The company offers minimally invasive therapies for treatment of end stage renal disease. It offers everlinq, an endovascular device used for creating an AV fistula for hemodialysi …
  • The Arab Contractors Osman Ahmed Osman & Co:企業の戦略・SWOT・財務情報
    The Arab Contractors Osman Ahmed Osman & Co - Strategy, SWOT and Corporate Finance Report Summary The Arab Contractors Osman Ahmed Osman & Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • SugarBud Craft Growers Corp (RRL):企業の財務・戦略的SWOT分析
    Summary SugarBud Craft Growers Corp, (SugarBud) formerly New Range Resources Ltd is an oil and gas company that offers oil and gas exploration and development services. The company acquires, explores, operates, manages, produces, and develops crude oil and natural gas in Alberta and Saskatchewan. It …
  • Micromem Technologies Inc (MRM):企業の財務・戦略的SWOT分析
    Summary Micromem Technologies Inc (Micromem) operates as a technology company that develops and markets magnetic sensor products. The company designs and develops sensors specific to industrial requirements. It offers solutions such as nanoparticle detection solutions, structural integrity sensors, …
  • Trubnaya Metallurgicheskaya Kompaniya:企業の戦略・SWOT・財務情報
    Trubnaya Metallurgicheskaya Kompaniya - Strategy, SWOT and Corporate Finance Report Summary Trubnaya Metallurgicheskaya Kompaniya - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Pakistan State Oil Co Ltd (PSO):企業の財務・戦略的SWOT分析
    Pakistan State Oil Co Ltd (PSO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • AMETEK Inc (AME)-医療機器分野:企業M&A・提携分析
    Summary AMETEK Inc (AMETEK) is an electronic products manufacturing company that manufactures electronic instruments and electromechanical devices. The company's products include medical materials, motion control systems, sub assemblies and connectors, electrical cord reels, gauges, titanium alloys …
  • Henkel AG & Co KGaA (HEN3):企業の財務・戦略的SWOT分析
    Henkel AG & Co KGaA (HEN3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆